Insider Trading July 2, 2026 10:21 AM

SXI Director Thomas Chorman Executes Pre-Arranged Sale Amid Market Volatility

Transaction under 10b5-1 plan reduces direct holdings as Standex International navigates post-earnings adjustment

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
SXI

Thomas E. Chorman, serving as a director at Standex International Corp. (NYSE:SXI), executed a sale of company stock on July 1, 2026, totaling $17,775. The transaction, conducted at $355.51 per share, involved the disposal of 50 shares and was processed under a pre-arranged 10b5-1 trading plan established on November 6, 2025. Following this activity, Chorman's direct ownership in Standex International Corp. remains at 12,416 shares. The sale occurs against a backdrop of significant market movement, with Standex shares having appreciated over 110% in the trailing twelve months. Current trading data places the stock at $338.80, supporting a market capitalization of $4.17 billion. Independent analysis suggests the valuation may be stretched, citing a P/E ratio of 41.66 relative to fair value estimates. Concurrently, the company reported fiscal third-quarter 2026 results that slightly missed consensus expectations on both earnings per share and revenue. Management has also announced internal structural changes, including the promotion of Ademir Sarcevic to Executive Vice President-Corporate and Group President-Electronics, while he retains his Chief Financial Officer duties pending a successor.

SXI Director Thomas Chorman Executes Pre-Arranged Sale Amid Market Volatility
SXI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Thomas E. Chorman sold 50 shares of Standex International Corp. (SXI) for $17,775 under a pre-arranged 10b5-1 plan, reducing his direct holdings to 12,416 shares.
  • SXI shares have surged over 110% in the past year, trading at $338.80 with a market cap of $4.17 billion, though valuation metrics suggest the stock may be overvalued relative to fair value.
  • Standex reported a slight miss on fiscal Q3 2026 EPS ($2.21 vs $2.23 forecast) and revenue ($224.6M vs $225.76M forecast), while announcing the promotion of Ademir Sarcevic to Executive Vice President-Corporate and Group President-Electronics.

Thomas E. Chorman, a director at Standex International Corp. (NYSE:SXI), executed a transaction involving the sale of company equity on July 1, 2026. The total value of the sale was recorded at $17,775. This financial activity was processed at a per-share price of $355.51. The execution of this trade was conducted in strict accordance with a pre-arranged 10b5-1 trading plan, which was originally established on November 6, 2025.


As a result of this disposition, Chorman reduced his holdings by 50 shares of common stock. Following the completion of this transaction, his direct ownership stake in Standex International Corp. is reported to stand at 12,416 shares. This insider activity occurs against a backdrop of substantial price appreciation for the equity. Over the past year, Standex shares have appreciated by more than 110%. Current market data indicates the stock is trading at $338.80, which corresponds to a total market capitalization of $4.17 billion.


Valuation metrics present a complex picture for the industrial conglomerate. According to analysis derived from InvestingPro, the stock's current price point appears elevated relative to its established Fair Value. The company is currently trading at a Price-to-Earnings ratio of 41.66. For investors seeking deeper fundamental insights, comprehensive Pro Research Reports are available for SXI and over 1,400 other US equities.


Concurrent with these market movements, Standex International Corporation reported its fiscal third-quarter 2026 earnings results. The financial report indicated a slight miss on both earnings per share and revenue forecasts. The company posted an earnings per share of $2.21, which fell just below the consensus forecast of $2.23. Revenue was reported at $224.6 million, which did not meet the expected figure of $225.76 million.


Despite the minor misses against consensus estimates, Standex demonstrated robust year-over-year growth. Total revenue increased by 8.1% compared to the prior year period. In a separate development regarding corporate governance and leadership, Standex announced the promotion of Ademir Sarcevic to the role of Executive Vice President-Corporate and Group President-Electronics. Sarcevic will assume oversight of the company’s Electronics segment and specific corporate projects. He will continue to serve as Chief Financial Officer until a successor is appointed.


These operational updates and leadership changes mark significant structural adjustments for the company. The confluence of insider selling, valuation metrics, and earnings performance requires careful monitoring by market participants. Standex (SXI) real-time data reflects a price of 339.50, representing a decline of 8.96 or 2.57% in recent trading sessions. The intersection of executive transactions and fundamental results continues to shape the narrative around Standex International Corp.

Risks

  • Valuation Risk: Standex International Corp. trades at a P/E ratio of 41.66, which analysis suggests may be overvalued relative to its Fair Value, indicating potential downside risk if multiples compress.
  • Earnings Miss Risk: The company reported fiscal Q3 2026 results that slightly missed both EPS and revenue forecasts, which could impact short-term market sentiment and investor confidence in the industrial sector.
  • Leadership Transition Risk: The promotion of Ademir Sarcevic to Executive Vice President-Corporate and Group President-Electronics, while he retains CFO duties, introduces interim management uncertainty until a successor is appointed for the CFO role.

More from Insider Trading

Williams Companies Executive Wilson Lane Executes $148K Stock Sale Under Pre-Arranged Plan Jul 2, 2026 Finward Bancorp Director Johnson Expands Stake via Dividend Reinvestment Jul 2, 2026 Keysight Senior Vice President Executes Pre-Arranged Stock Sale Jul 2, 2026 Cadrenal Therapeutics CEO Pham Executes Pre-Arranged Stock Sale Jul 1, 2026 Qualys CEO Executes $4.05 Million Stock Sale Under Pre-Arranged Trading Plan Jul 1, 2026